LunX, a novel human lung-specific gene, has been reported to be a superior diagnostic marker for the detection of micrometastases in lymph nodes and peripheral blood of NSCLC patients [1,6,13]. Here, BPIFA1 is linked to non-small cell lung carcinoma.